Indefinite Delivery Contract 75F40118D10043

Award Date 9/18/18
Last Date to Order 9/20/23
Ultimate Awardee
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The $10 million master IDIQ contract, titled "Tobacco Products Pharmacology Study", is focused on regulatory and scientific efforts related to tobacco products under the FDA's purview. The contract has resulted in several firm fixed-price delivery orders to Battelle, valued at...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to the non-profit Research Triangle Institute (RTI) International. The contract, valued up to $2,500,000, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract includes two firm fixed-price delivery orders issued to date. The first...
The Indefinite Delivery Contract (IDC) with award ID 75F40124D00062 was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Rhode Island Department of Behavioral Healthcare and Developmental Disabilities (BHDDH) as the prime contractor. The contract, with a ceiling value of $4,537,726, is for the provision of compliance and enforcement tobacco retailer inspections across the state of Rhode Island over a period of approximately 5 years, with a scheduled completion...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Northstar Technology Corp., a woman-owned small business. The contract has a total ceiling value of $1,000,000 and was set aside for the 8(a) small business program. The purpose of the contract is to acquire tobacco products for testing and analysis by the FDA. Under this IDV, Northstar has been issued several firm-fixed price delivery orders to provide a variety of tobacco...
The U.S. Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, valued at $5 million, to Labstat International Inc., a Canadian for-profit limited liability company, to provide tobacco analysis laboratory services over a 5-year period. This IDIQ contract allows the FDA to issue multiple firm fixed-price delivery orders for chemical, physical, and microbiological testing of tobacco, e-cigarette, cannabis, and CBD products in support of...
The Department of Health and Human Services' Food and Drug Administration (HHS FDA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $10,000,000 to Battelle Memorial Institute, a non-profit research and development organization, to provide technical research and support services related to food protection and supply chain integrity. The contract has been used to issue multiple task orders, including: $419,634.41 for technical support services related to National Security...
The Food and Drug Administration (FDA) awarded a $75 million single-award Indefinite Delivery Contract to Ivyhill Technologies LLC, a certified 8(a), HUBZone, and Economically Disadvantaged Women-Owned Small Business. The contract is for pre-existing tobacco products and internet surveillance services. Task orders awarded under this IDC include: A $1.8 million task order for internet surveillance and monitoring of the marketing, sale, promotion, and advertising activities of regulated tobacco...
The provided materials describe a federal Indefinite Delivery Contract (IDC) awarded by the U.S. Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH). The $9,053,849 single-award IDC has an ultimate completion date of September 29, 2029 and provides for the delivery of tobacco inspection and compliance services within the state of Massachusetts. The contract is a delivery order issued under the larger IDC vehicle, with a ceiling value of $744,510.20 and an...
The Indefinite Delivery Contract (IDC) awarded by the Assisted Acquisition Services FEDSIM division of the General Services Administration (GSA) to Battelle Memorial Institute (Battelle) aims to procure a broad range of platform-related services. The $3.5 million multiple-award contract has a period of performance lasting until November 14, 2031. Battelle, a non-profit research and development organization, will provide the government with scientific, engineering, testing, manufacturing, and...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $6,956,369.00, awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Tobacco Control Board Arkansas. The contract has an ultimate completion date of September 28, 2029 and was awarded on September 27, 2024. The purpose of this IDC is to provide comprehensive tobacco inspection and compliance services to support the FDA's regulatory responsibilities for...

The Indefinite Delivery Contract (IDC) 75F40118D10043 was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Battelle Memorial Institute, doing business as Battelle, a nonprofit organization and manufacturer of goods. The contract provides $2,500,000.00 in ceiling value for Engineering Analysis Laboratory Services for ENDS (electronic nicotine delivery systems) and Other Newly Deemed Tobacco Products. This IDC is a multiple award vehicle under the broader Engineering Analysis Laboratory Services master IDIQ contract, with a period of performance through September 20, 2023. The original solicitation, posted on July 10, 2018, did not utilize any set-asides. Battelle, as the prime contractor, will leverage its extensive scientific resources and technical capabilities across chemical, biological, and engineering fields to perform research, testing, and analysis services to support the FDA's regulatory oversight of ENDS and other newly deemed tobacco products. This contract enables the FDA flexible access to Battelle's expertise to address complex challenges related to these emerging tobacco product categories.

Generated 9/7/24, 10:09 AM